An observational/translational study to conduct real-world evidence and develop biomarkers of fruquintinib for patients with metastatic colorectal cancer (mCRC): FruBLOOM trial (JACCRO CC-19).

Authors: Yu Sunakawa, Chiaki Inagaki, Satoshi Yuki, Kota Ouchi, Toshihiro Kudo, Hironaga Satake, Tomomi Kashiwada, Eisuke Inoue, Ryo Matoba, Wataru Ichikawa

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps3637

Source: Full article

---

Abstract

TPS3637